RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer-Reference-Cited by-同舟云学术

RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer

Published:2018-11-19 Issue:1 Volume:6 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Ledys Fanny,Klopfenstein Quentin,Truntzer Caroline,Arnould Laurent,Vincent Julie,Bengrine Leila,Remark Romain,Boidot Romain,Ladoire Sylvain,Ghiringhelli Francois,Derangere Valentin^ORCID

Funder

Ligue Contre le Cancer

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0438-3.pdf

Reference28 articles.

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.

2. Tanis E, Julié C, Emile J-F, Mauer M, Nordlinger B, Aust D, et al. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983. Eur J Cancer. 2015;51(17):2708–17.

3. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–15.

4. House AK, Watt AG. Survival and the immune response in patients with carcinoma of the colorectum. Gut. 1979;20(10):868–74.

5. Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer and prognosis: cohort study and literature review. J Pathol. 2010;222(4):350–66.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic pan-cancer analysis of RNF186 with potential implications in progression and prognosis in human cancer;Life Sciences;2024-02

2. Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor–based combination therapy;Cancer;2023-12-29

3. First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial;Nature Medicine;2023-08

4. Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?;Frontiers in Immunology;2023-03-06

5. The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors;Frontiers in Oncology;2022-11-08